Stay updated on LNP023 in IgA Nephropathy: Clinical Trial
Sign up to get notified when there's something new on the LNP023 in IgA Nephropathy: Clinical Trial page.

Latest updates to the LNP023 in IgA Nephropathy: Clinical Trial page
- ChecktodayChange DetectedResults for the APPLAUSE-IgAN study are now posted, with information on outcome measures, participant flow, and adverse events. The record history also reflects a new version dated 2026-10-13.SummaryDifference0.6%

- Check7 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedA site-wide NIH banner announces a terminology transition, stating that federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference0.4%

- Check21 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check35 days agoChange DetectedA new study-record version dated 2026-09-04 is listed, covering updates to trial identification, status, description, eligibility, outcomes, contacts, and results sections. Its quality-control review has not concluded, and it was returned on 2026-09-29.SummaryDifference0.9%

Stay in the know with updates to LNP023 in IgA Nephropathy: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LNP023 in IgA Nephropathy: Clinical Trial page.